Tirzepatide 10 to 100 mg

Dual GIP and GLP-1 agonist

A single peptide that activates two receptors at once: GIP and GLP-1. Its backbone derives from the GIP sequence and carries a C20 fatty-acid chain that binds albumin and extends its duration to about a week. In the head-to-head obesity trial against semaglutide it produced greater weight reduction; that trial was open-label, without blinding.

CAS: 2023788-19-2. Lyophilized powder: -20 °C, stable.

Articles

• Retatrutide vs tirzepatide: two receptors against three, and how much evidence each one has
• Tirzepatide in Costa Rica: what it is, what the studies measured, and what to check in the vial

• Tirzepatide 10 mg: $110
• Tirzepatide 15 mg: $135
• Tirzepatide 30 mg: $210
• Tirzepatide 60 mg: $260
• Tirzepatide 100 mg: $300

For research use only. Not for human consumption.

See it in the store · Articles